Calder Biosciences, Inc.

Calder Biosciences, Inc.

Calder Biosciences, Inc. is a nano-scale molecular engineering company that is applying its platform technology to develop novel respiratory syncytial virus (RSV) and universal Influenza vaccines that both represent multi-billion dollar market opportunities with mitigated clinical risk.

Company details

140 58th Street, Bldg A, Unit 8J, Brooklyn, New York 11220 

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Pharmaceuticals
Market Focus:
Nationally (across the country)
This company also provides solutions for other industrial applications. Please, visit the following links for more info: